Anti-IFRD1 antibody (ab229720)
Key features and details
- Rabbit polyclonal to IFRD1
- Suitable for: WB, IHC-P
- Reacts with: Mouse, Human
- Isotype: IgG
Overview
-
Product name
Anti-IFRD1 antibody
See all IFRD1 primary antibodies -
Description
Rabbit polyclonal to IFRD1 -
Host species
Rabbit -
Tested applications
Suitable for: WB, IHC-Pmore details -
Species reactivity
Reacts with: Mouse, Human -
Immunogen
Recombinant fragment corresponding to Human IFRD1 aa 1-240.
Database link: O00458 -
Positive control
- WB: HeLa and Jurkat whole cell lysate (ab7899); mouse skeletal muscle tissue lysate. IHC-P: Human brain and adrenal gland tissues.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.30
Preservative: 0.02% Sodium azide
Constituents: PBS, 50% Glycerol (glycerin, glycerine) -
Concentration information loading... -
Purity
Immunogen affinity purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Images
-
Western blot - Anti-IFRD1 antibody (ab229720)All lanes : Anti-IFRD1 antibody (ab229720) at 1/1000 dilution
Lane 1 : Mouse skeletal muscle tissue lysate
Lane 2 : HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate
Lane 3 : Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate
Secondary
All lanes : Goat polyclonal to Rabbit IgG at 1/10000 dilution
Predicted band size: 50, 45 kDa
Observed band size: 50 kDa why is the actual band size different from the predicted?
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFRD1 antibody (ab229720)Paraffin-embedded human brain tissue stained for IFRD1 using ab229720 at 1/100 dilution in immunohistochemical analysis.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFRD1 antibody (ab229720)Paraffin-embedded human adrenal gland tissue stained for IFRD1 using ab229720 at 1/100 dilution in immunohistochemical analysis.
